Linking comfort levels and knowledge gaps in hematology/oncology (HO) fellowship education: Insights from a multicenter survey.

R Ronak Mistry (2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States) K Karine Tawagi (2University of Illinois Chicago, Chicago, United States) S Samantha Ann Armstrong (Indiana University School of Medicine, Indianapolis, IN) D Daniel Hausrath (2Vanderbilt University Medical Center, Nashville, United States) I Inas Abuali (Mass General Brigham Cancer Institute, Boston, MA) D Dillon Cockrell (Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC) K Kayla Weiss Miranda (Baylor College of Medicine, Houston, TX) A Ahmad M. Nassar (University of Illinois Chicago, Chicago, IL) Y Yurhee Lee (Olive View-UCLA Medical Center, Sylmar, CA) V Victoria Chung (UT Southwestern Medical Center, Dallas, TX) F Fadi Taza (Community Health MD Anderson Cancer Center, Indianapolis, IN) M Matthew D Bloom (Thomas Jefferson University, Philadelphia, PA) D Daniel Egert (Penn State Milton S. Hershey Medical Center, Hershey, PA) G Giuliana Berardi (1Fox Chase Cancer Center, Hematology Oncology, Philadelphia, United States) M Madeline Campbell Fitzpatrick (Dell Medical School, The University of Texas at Austin, Austin, TX) A Aleena Itani (Texas Oncology, Flower-Mound, TX) E Ericson Stoen (Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC) N Nathaniel R. Wilson (Emory University School of Medicine, Atlanta, GA) V Vivek Patel

Abstract

9030 Background: HO fellowship programs lack standardized educational approaches. This can impact learning & self-assessment of learning gaps. This study investigates the relationship between HO fellows’ (HOF) comfort levels & objective knowledge assessments across diverse HO topics, addressing a critical need for data in this area. Methods: HOF from 27 U.S. programs were invited to complete an anonymous survey (Sept-Oct 2023) in which they rated their comfort managing representative HO diseases, namely breast cancer (BC), plasma cell dyscrasias (PCD), hemophilia, von Willebrand disease (vWD), & heparin-induced thrombocytopenia (HIT), on a 7-point Likert scale (1 = extremely uncomfortable, 7 = extremely comfortable). An optional multiple choice knowledge quiz on these topics followed, including an option for “not sure & need to look it up.” Fellows were categorized into low (1–3), moderate (4–5), & high (6–7) comfort groups. One-way ANOVA assessed differences in knowledge scores by comfort levels. Results: In total,222 HOF completed the comfort survey (53% response rate): 82 PGY4 (37%), 72 PGY5 (32%), & 69 PGY6+ (31%). Also, 189 HOF completed the knowledge quiz (46% response rate): 71 PGY4 (38%), 57 PGY5 (30%), & 60 PGY6+ (31%). Mean comfort levels (±SD) were: BC diagnosis 4.8±1.4, localized BC management (mgmt.) 4.2±1.5, metastatic BC mgmt. 4.2±1.5, PCD diagnosis 4.8±1.4, MGUS/smoldering myeloma mgmt. 4.7±1.4, front-line myeloma treatment 4.5±1.6, maintenance myeloma treatment 4.1±1.5, inherited/acquired hemophilia mgmt. 3.7±1.5, vWD diagnosis 4±1.4, vWD mgmt. 3.8±1.4, HIT diagnosis 5.4±1.1, & HIT mgmt. 5.4±1.1. Mean knowledge scores were 41% for BC, 39% for PCD, 47% for hemophilia, 33% for vWD, & 51% for HIT. When evaluated by comfort level groups (low, medium, & high), knowledge scores increased significantly with higher comfort levels for BC (25%, 43%, 55%; p<0.01), PCD (25%, 38%, 51%; p<0.01), hemophilia (29%, 55%, 77%; p<0.01), & vWD (13%, 39%, 62%; p<0.01). HIT scores showed no significant difference by comfort levels (p=0.89). The number of “not sure” responses (%) significantly decreased (p<0.01) with greater comfort across topics: BC (53%, 20%, 10%), PCD (39%, 23%, 7%), hemophilia (52%, 28%, 2%), vWD (69%, 40%, 12%). HIT “not sure” responses showed no significant difference by comfort levels. Conclusions: This multicenter analysis demonstrates a correlation between HOF comfort levels & knowledge assessments. Despite overall low performance on knowledge tests, comfort levels effectively discriminated between knowledge groups, underscoring their potential utility as a surrogate for educational progress. These data highlight the need for interventions to bridge gaps between perceived & actual knowledge. Future studies to validate these results across broader topics & institutions to inform optimal education strategies in HO training programs are needed.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 9030-9030
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (19)

R

Ronak Mistry

2University of Pennsylvania Perelman School of Medicine, Division of Hematology/Oncology, Philadelphia, United States

K

Karine Tawagi

2University of Illinois Chicago, Chicago, United States

S

Samantha Ann Armstrong

Indiana University School of Medicine, Indianapolis, IN

D

Daniel Hausrath

2Vanderbilt University Medical Center, Nashville, United States

I

Inas Abuali

Mass General Brigham Cancer Institute, Boston, MA

D

Dillon Cockrell

Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC

K

Kayla Weiss Miranda

Baylor College of Medicine, Houston, TX

A

Ahmad M. Nassar

University of Illinois Chicago, Chicago, IL

Y

Yurhee Lee

Olive View-UCLA Medical Center, Sylmar, CA

V

Victoria Chung

UT Southwestern Medical Center, Dallas, TX

F

Fadi Taza

Community Health MD Anderson Cancer Center, Indianapolis, IN

M

Matthew D Bloom

Thomas Jefferson University, Philadelphia, PA

D

Daniel Egert

Penn State Milton S. Hershey Medical Center, Hershey, PA

G

Giuliana Berardi

1Fox Chase Cancer Center, Hematology Oncology, Philadelphia, United States

M

Madeline Campbell Fitzpatrick

Dell Medical School, The University of Texas at Austin, Austin, TX

A

Aleena Itani

Texas Oncology, Flower-Mound, TX

E

Ericson Stoen

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC

N

Nathaniel R. Wilson

Emory University School of Medicine, Atlanta, GA

V

Vivek Patel